Coronavirus Host Entry

The entry of coronaviruses into susceptible host cells is mediated by the viral S (Spike) glycoprotein. This feed covers latest findings about this complex process and the ongoing research efforts into finding therapeutics that can target the viral Spike protein and hence disrupt virus-cell fusion.

May 8, 2020

Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein

Journal of Clinical Pathology
Tahir S Pillay
May 27, 2020

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Nature
Bin JuLinqi Zhang
May 21, 2020

SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review

Expert Opinion on Therapeutic Patents
José Adão Carvalho Nascimento JuniorMairim Russo Serafini
May 18, 2020

Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery

Current Topics in Medicinal Chemistry
Ariane SternbergCord Naujokat
May 7, 2020
Review

The viral, epidemiologic, clinical characteristics and potential therapy options for COVID-19: a review

European Review for Medical and Pharmacological Sciences
C Li, B-H Xu
May 12, 2020
ReviewOpen Access

A Precision Medicine Approach to SARS-CoV-2 Pandemic Management

Current Treatment Options in Allergy
Carlos D CrisciLeila Müller
May 25, 2020
Review

COVID-19 and the nervous system

Journal of Neurovirology
Joseph R Berger
May 18, 2020

ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
Christian A DevauxDidier Raoult
May 7, 2020
Open Access

DC/L-SIGNs of Hope in the COVID-19 Pandemic

Journal of Medical Virology
Adam Brufsky, Michael T Lotze
May 22, 2020

Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management

Journal of Translational Internal Medicine
Mengyuan LiuJianping Li

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/coronavirus-host-entry/fd62c2d6-4218-4fb6-afbd-6cbabe505b64